Mark Alan Goldberg Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Mark Alan Goldberg.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Mark Alan Goldberg. Mark Alan Goldberg is a Director in IMMUNOGEN INC ($IMGN) and a Director in IDERA PHARMACEUTICALS, INC. ($IDRA) and a Director in GLYCOMIMETICS INC ($GLYC) and a Director in aTYR PHARMA INC ($LIFE) and a Director in Blueprint Medicines Corp ($BPMC) and a Director in Audentes Therapeutics, Inc. ($BOLD).
Address: 41 GRASMERE ROAD NEEDHAM 02494 MA
Companies in which Mark Alan Goldberg is an Insider
aTYR PHARMA INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: May 11 2017
$LIFE Market Capitalization: $78.27M
$LIFE Previous Close: $3.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Audentes Therapeutics, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 15 2020
$BOLD Market Capitalization: $337.82M
$BOLD Previous Close: $15.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Blueprint Medicines Corp
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Alan Goldberg: Director
Holdings: 9,017 shares
Current Value: $323,169
Latest Transaction: Dec 28 2020
$BPMC Market Capitalization: $979.55M
$BPMC Previous Close: $35.84
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GLYCOMIMETICS INC
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Alan Goldberg: Director
Holdings: 5,250 shares
Current Value: $32,865
Latest Transaction: May 27 2021
$GLYC Market Capitalization: $140.70M
$GLYC Previous Close: $6.26
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IDERA PHARMACEUTICALS, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of Mark Alan Goldberg: Director
Holdings: 38,099 shares
Current Value: $59,434
Latest Transaction: Jan 06 2021
$IDRA Market Capitalization: $230.34M
$IDRA Previous Close: $1.56
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ImmunoGen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Mark Alan Goldberg: Director
Holdings: 53,800 shares
Current Value: $128,044
Latest Transaction: Apr 02 2021
$IMGN Market Capitalization: $205.16M
$IMGN Previous Close: $2.38
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of Mark Alan Goldberg
Sentiment: All, LIFE, BOLD, BPMC, GLYC, IDRA, IMGN
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Option Exercise | A | 2.55 | 10,500 | 26,775 | 10,500 | |
| May 27 2021 | GLYC | GLYCOMIMETICS INC | Goldberg Mark Alan | Director | Grant | A | 0.00 | 5,250 | 0 | 5,250 | 0 to 5.3 K |
| Apr 02 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 1,666 | 0 | 109,876 | |
| Jan 06 2021 | IDRA | IDERA PHARMACEUTIC ... | Goldberg Mark Alan | Director | Grant | A | 4.02 | 3,452 | 13,877 | 38,099 | 34.6 K to 38.1 K (+9.96 %) |
| Jan 04 2021 | IMGN | ImmunoGen, Inc. | Goldberg Mark Alan | Director | Option Exercise | A | 0.00 | 2,093 | 0 | 108,210 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Option Exercise | M | 28.15 | 5,455 | 153,558 | 0 | |
| Dec 28 2020 | BPMC | Blueprint Medicine ... | Goldberg Mark Alan | Director | Sell | S | 125.00 | 5,455 | 681,875 | 3,562 | 9 K to 3.6 K (-60.50 %) |